Dermochelys coriacea isolate rDerCor1 chromosome 27, rDerCor1.pri.v4, whole genome shotgun sequence.
Dermochelys coriacea (leatherback sea turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Dermochelyidae; Dermochelys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM019961.3.\nAssembly name: rDerCor1.pri.v4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the G10K on 2021/08/25. The\noriginal whole-genome shotgun project has the accession\nWSPL00000000.4.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: G10K\nAssembly Date :: 24-MAY-2021\nAssembly Method :: FALCON DNANexus v. 1.9.0; FALCON-Unzip\n DNANexus v. 1.0.6; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.2.1; Salsa HiC v. 2.2.2; Arrow\n smrtanalysis Pacbio polishing & gap\n filling v. 6.0.0.47841; longranger align\n v. 2.2.2; freebayes Illumina polishing v.\n 1.3.1; gEVAL manual curation v.\n 2021-05-24; VGP assembly pipeline\n individual v. 1.6\nAssembly Name :: rDerCor1.pri.v4\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 63.68x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Dermochelys coriacea Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
vasoactive intestinal polypeptide receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
sodium voltage-gated channel alpha subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
sodium channel protein type 4 subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
B-cell antigen receptor complex-associated protein beta chain
uncharacterized LOC122457596, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122457596, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC122457596, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122457596, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAD52 motif containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RAD52 motif containing 1, transcript variant X4
RAD52 motif containing 1, transcript variant X1
RAD52 motif containing 1, transcript variant X7
RAD52 motif containing 1, transcript variant X2
RAD52 motif containing 1, transcript variant X6
RAD52 motif containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
RAD52 motif containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RAD52 motif containing 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RAD52 motif-containing protein 1 isoform X1
RAD52 motif-containing protein 1 isoform X2
RAD52 motif-containing protein 1 isoform X4
RAD52 motif-containing protein 1 isoform X5
RAD52 motif-containing protein 1 isoform X3
RAD52 motif-containing protein 1 isoform X6
RAD52 motif-containing protein 1 isoform X7
leucine-rich repeat-containing protein 37A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pleckstrin homology and RUN domain containing M1, transcript variant X1
pleckstrin homology and RUN domain containing M1, transcript variant X3
pleckstrin homology and RUN domain containing M1, transcript variant X4
pleckstrin homology and RUN domain containing M1, transcript variant X2
pleckstrin homology domain-containing family M member 1 isoform X1
pleckstrin homology domain-containing family M member 1 isoform X2
Rho GTPase activating protein 27, transcript variant X1
rho GTPase-activating protein 27 isoform X1
Rho GTPase activating protein 27, transcript variant X3
rho GTPase-activating protein 27 isoform X3
Rho GTPase activating protein 27, transcript variant X2
rho GTPase-activating protein 27 isoform X2
transmembrane protein 98, transcript variant X2
transmembrane protein 98, transcript variant X3
transmembrane protein 98, transcript variant X1
granulin precursor, transcript variant X2
granulin precursor, transcript variant X8
granulin precursor, transcript variant X3
granulin precursor, transcript variant X7
granulin precursor, transcript variant X1
granulin precursor, transcript variant X6
granulin precursor, transcript variant X4
granulin precursor, transcript variant X5
family with sequence similarity 171 member A2
integrin subunit alpha 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
integrin subunit alpha 2b, transcript variant X1
integrin subunit alpha 2b, transcript variant X3
integrin subunit alpha 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
integrin subunit alpha 2b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
G-patch domain containing 8, transcript variant X1
G-patch domain containing 8, transcript variant X2
G-patch domain containing 8, transcript variant X3
G-patch domain containing 8, transcript variant X6
G-patch domain containing 8, transcript variant X4
G-patch domain containing 8, transcript variant X5
G patch domain-containing protein 8 isoform X1
G patch domain-containing protein 8 isoform X2
G patch domain-containing protein 8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 11
cyclin dependent kinase 5 regulatory subunit 1, transcript variant X1
cyclin dependent kinase 5 regulatory subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122457609, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122457609, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122457609, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122457609, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122457609, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122457609, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122457609, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 14, transcript variant X3
mitogen-activated protein kinase kinase kinase 14, transcript variant X2
mitogen-activated protein kinase kinase kinase 14, transcript variant X1
mitogen-activated protein kinase kinase kinase 14
myosin light chain kinase, smooth muscle-like, transcript variant X1
myosin light chain kinase, smooth muscle-like, transcript variant X2
myosin light chain kinase, smooth muscle-like
acyl-CoA binding domain containing 4, transcript variant X3
acyl-CoA binding domain containing 4, transcript variant X1
acyl-CoA binding domain containing 4, transcript variant X2
acyl-CoA binding domain containing 4, transcript variant X6
acyl-CoA binding domain containing 4, transcript variant X5
acyl-CoA binding domain containing 4, transcript variant X4
acyl-CoA-binding domain-containing protein 4 isoform X1
acyl-CoA-binding domain-containing protein 4 isoform X2
phospholipase C delta 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phospholipase C delta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 isoform X3
phospholipase C delta 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 isoform X2
dephospho-CoA kinase domain containing, transcript variant X3
N-myristoyltransferase 1, transcript variant X1
N-myristoyltransferase 1, transcript variant X2
glycylpeptide N-tetradecanoyltransferase 1 isoform X1
glycylpeptide N-tetradecanoyltransferase 1 isoform X2
dephospho-CoA kinase domain containing, transcript variant X6
dephospho-CoA kinase domain containing, transcript variant X4
dephospho-CoA kinase domain containing, transcript variant X2
dephospho-CoA kinase domain containing, transcript variant X7
dephospho-CoA kinase domain containing, transcript variant X1
dephospho-CoA kinase domain containing, transcript variant X5
dephospho-CoA kinase domain-containing protein isoform X1
dephospho-CoA kinase domain-containing protein isoform X2
dephospho-CoA kinase domain-containing protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
kinesin family member 18B, transcript variant X3
kinesin family member 18B, transcript variant X1
kinesin family member 18B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 463 long SRA reads, 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
family with sequence similarity 187 member A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: Ig-like V-type domain-containing protein FAM187A
coiled-coil domain-containing protein 103
elongation factor Tu GTP binding domain containing 2, transcript variant X1
elongation factor Tu GTP binding domain containing 2, transcript variant X2
116 kDa U5 small nuclear ribonucleoprotein component isoform X1
116 kDa U5 small nuclear ribonucleoprotein component isoform X2
HIG1 hypoxia inducible domain family member 1B
gap junction protein gamma 1, transcript variant X8
gap junction protein gamma 1, transcript variant X1
gap junction protein gamma 1, transcript variant X3
gap junction protein gamma 1, transcript variant X5
gap junction protein gamma 1, transcript variant X2
gap junction protein gamma 1, transcript variant X9
gap junction protein gamma 1, transcript variant X4
gap junction protein gamma 1, transcript variant X6
gap junction protein gamma 1, transcript variant X7
ADAM metallopeptidase domain 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADAM metallopeptidase domain 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ADAM metallopeptidase domain 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADAM metallopeptidase domain 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ADAM metallopeptidase domain 11, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 11 isoform X2
disintegrin and metalloproteinase domain-containing protein 11 isoform X1
disintegrin and metalloproteinase domain-containing protein 11 isoform X4
disintegrin and metalloproteinase domain-containing protein 11 isoform X3
disintegrin and metalloproteinase domain-containing protein 11 isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
DBF4 zinc finger B, transcript variant X4
DBF4 zinc finger B, transcript variant X2
DBF4 zinc finger B, transcript variant X6
DBF4 zinc finger B, transcript variant X1
DBF4 zinc finger B, transcript variant X5
DBF4 zinc finger B, transcript variant X3
coiled-coil domain-containing protein 43
meiosis specific with coiled-coil domain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
meiosis specific with coiled-coil domain, transcript variant X2
meiosis specific with coiled-coil domain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
meiosis-specific coiled-coil domain-containing protein MEIOC isoform X2
meiosis-specific coiled-coil domain-containing protein MEIOC isoform X4
meiosis-specific coiled-coil domain-containing protein MEIOC isoform X1
meiosis specific with coiled-coil domain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
meiosis-specific coiled-coil domain-containing protein MEIOC isoform X3
ADP-ribosylation factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADP-ribosylation factor 2, transcript variant X1
ADP-ribosylation factor 2, transcript variant X2
ADP-ribosylation factor 2, transcript variant X3
ADP-ribosylation factor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant X3
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant X1
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 86 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119849048, transcript variant X3
uncharacterized LOC119849048, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC119849048, transcript variant X1
golgi SNAP receptor complex member 2, transcript variant X1
golgi SNAP receptor complex member 2, transcript variant X2
Golgi SNAP receptor complex member 2 isoform X1
Golgi SNAP receptor complex member 2 isoform X2
zinc finger protein OZF-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X7
zinc finger protein OZF-like, transcript variant X4
zinc finger protein OZF-like, transcript variant X5
zinc finger protein OZF-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
zinc finger protein OZF-like isoform X10
non-structural maintenance of chromosomes element 3 homolog
zinc finger protein 569-like, transcript variant X3
zinc finger protein 569-like, transcript variant X2
zinc finger protein 569-like, transcript variant X1
zinc finger protein 569-like, transcript variant X4
zinc finger and SCAN domain-containing protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 2-like isoform X2
zinc finger and SCAN domain-containing protein 2-like isoform X3
zinc finger and SCAN domain-containing protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 isoform X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 isoform X2
FtsJ RNA 2'-O-methyltransferase 3, transcript variant X1
FtsJ RNA 2'-O-methyltransferase 3, transcript variant X2
pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3
acid sensing ion channel subunit 2, transcript variant X2
acid sensing ion channel subunit 2, transcript variant X3
acid sensing ion channel subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
corticotropin-releasing factor receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
integrin subunit beta 3, transcript variant X2
integrin subunit beta 3, transcript variant X1
uncharacterized LOC122457630, transcript variant X2
uncharacterized LOC122457630, transcript variant X1
EF-hand calcium-binding domain-containing protein 3
uncharacterized LOC122457632, transcript variant X4
uncharacterized LOC122457632, transcript variant X3
uncharacterized LOC122457632, transcript variant X2
uncharacterized LOC122457632, transcript variant X1
methyltransferase 2A, methylcytidine, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
methyltransferase 2A, methylcytidine, transcript variant X3
methyltransferase 2A, methylcytidine, transcript variant X2
methyltransferase 2A, methylcytidine, transcript variant X1
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X3
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X2
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase tousled-like 2
membrane associated ring-CH-type finger 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable E3 ubiquitin-protein ligase MARCHF10
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X3
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X4
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X7
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X1
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X5
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X6
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X8
transmembrane ascorbate-dependent reductase CYB561, transcript variant X9
transmembrane ascorbate-dependent reductase CYB561, transcript variant X1
transmembrane ascorbate-dependent reductase CYB561, transcript variant X10
transmembrane ascorbate-dependent reductase CYB561, transcript variant X3
transmembrane ascorbate-dependent reductase CYB561, transcript variant X6
transmembrane ascorbate-dependent reductase CYB561, transcript variant X2
transmembrane ascorbate-dependent reductase CYB561, transcript variant X7
transmembrane ascorbate-dependent reductase CYB561, transcript variant X4
transmembrane ascorbate-dependent reductase CYB561, transcript variant X5
transmembrane ascorbate-dependent reductase CYB561, transcript variant X8
transmembrane ascorbate-dependent reductase CYB561
angiotensin I converting enzyme, transcript variant X1
angiotensin I converting enzyme, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
potassium voltage-gated channel subfamily H member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitogen-activated protein kinase kinase kinase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 3, transcript variant X1
mitogen-activated protein kinase kinase kinase 3, transcript variant X2
mitogen-activated protein kinase kinase kinase 3 isoform X1
mitogen-activated protein kinase kinase kinase 3 isoform X2
mitogen-activated protein kinase kinase kinase 3 isoform X3
LIM domain containing 2, transcript variant X3
LIM domain containing 2, transcript variant X1
LIM domain containing 2, transcript variant X2
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X3
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X1
E3 ubiquitin-protein ligase RNF113A-like isoform X1
E3 ubiquitin-protein ligase RNF113A-like isoform X3
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X2
E3 ubiquitin-protein ligase RNF113A-like isoform X2
STE20 related adaptor alpha, transcript variant X1
STE20 related adaptor alpha, transcript variant X10
STE20 related adaptor alpha, transcript variant X20
STE20 related adaptor alpha, transcript variant X18
STE20 related adaptor alpha, transcript variant X6
STE20 related adaptor alpha, transcript variant X16
STE20 related adaptor alpha, transcript variant X5
STE20 related adaptor alpha, transcript variant X9
STE20 related adaptor alpha, transcript variant X11
STE20 related adaptor alpha, transcript variant X21
STE20 related adaptor alpha, transcript variant X8
STE20 related adaptor alpha, transcript variant X12
STE20 related adaptor alpha, transcript variant X15
STE20 related adaptor alpha, transcript variant X19
STE20 related adaptor alpha, transcript variant X4
STE20 related adaptor alpha, transcript variant X7
STE20 related adaptor alpha, transcript variant X22
STE20 related adaptor alpha, transcript variant X13
STE20 related adaptor alpha, transcript variant X2
STE20 related adaptor alpha, transcript variant X14
STE20 related adaptor alpha, transcript variant X3
STE20 related adaptor alpha, transcript variant X17
STE20 related adaptor alpha, transcript variant X24
STE20 related adaptor alpha, transcript variant X23
STE20-related kinase adapter protein alpha isoform X4
STE20-related kinase adapter protein alpha isoform X2
STE20-related kinase adapter protein alpha isoform X3
STE20-related kinase adapter protein alpha isoform X1
STE20-related kinase adapter protein alpha isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
coiled-coil domain containing 47, transcript variant X1
coiled-coil domain containing 47, transcript variant X5
coiled-coil domain containing 47, transcript variant X2
coiled-coil domain containing 47, transcript variant X4
coiled-coil domain containing 47, transcript variant X3
coiled-coil domain containing 47, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
DEAD-box helicase 42, transcript variant X3
DEAD-box helicase 42, transcript variant X1
DEAD-box helicase 42, transcript variant X2
ATP-dependent RNA helicase DDX42 isoform X1
ATP-dependent RNA helicase DDX42 isoform X2
DEAD-box helicase 42, transcript variant X4
ATP-dependent RNA helicase DDX42 isoform X3
parathyroid hormone/parathyroid hormone-related peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 27, transcript variant X7
cell division cycle 27, transcript variant X8
cell division cycle 27, transcript variant X5
cell division cycle 27, transcript variant X6
cell division cycle 27, transcript variant X1
cell division cycle 27, transcript variant X3
cell division cycle 27, transcript variant X2
cell division cycle 27, transcript variant X4
cell division cycle protein 27 homolog isoform X1
cell division cycle protein 27 homolog isoform X3
cell division cycle protein 27 homolog isoform X2
cell division cycle protein 27 homolog isoform X4
cell division cycle protein 27 homolog isoform X5
cell division cycle protein 27 homolog isoform X6
cell division cycle protein 27 homolog isoform X7
cell division cycle protein 27 homolog isoform X8
cell division cycle 27, transcript variant X10
cell division cycle 27, transcript variant X9
cell division cycle protein 27 homolog isoform X9
KAT8 regulatory NSL complex subunit 1, transcript variant X6
KAT8 regulatory NSL complex subunit 1, transcript variant X1
KAT8 regulatory NSL complex subunit 1, transcript variant X10
KAT8 regulatory NSL complex subunit 1, transcript variant X11
KAT8 regulatory NSL complex subunit 1, transcript variant X7
KAT8 regulatory NSL complex subunit 1, transcript variant X3
KAT8 regulatory NSL complex subunit 1, transcript variant X2
KAT8 regulatory NSL complex subunit 1, transcript variant X8
KAT8 regulatory NSL complex subunit 1, transcript variant X5
KAT8 regulatory NSL complex subunit 1, transcript variant X9
KAT8 regulatory NSL complex subunit 1, transcript variant X4
KAT8 regulatory NSL complex subunit 1 isoform X1
KAT8 regulatory NSL complex subunit 1 isoform X2
KAT8 regulatory NSL complex subunit 1 isoform X4
KAT8 regulatory NSL complex subunit 1 isoform X3
microtubule associated protein tau, transcript variant X14
microtubule associated protein tau, transcript variant X15
microtubule associated protein tau, transcript variant X12
microtubule associated protein tau, transcript variant X9
microtubule associated protein tau, transcript variant X5
microtubule associated protein tau, transcript variant X13
microtubule associated protein tau, transcript variant X11
microtubule associated protein tau, transcript variant X6
microtubule associated protein tau, transcript variant X10
microtubule associated protein tau, transcript variant X7
microtubule associated protein tau, transcript variant X1
microtubule associated protein tau, transcript variant X3
microtubule associated protein tau, transcript variant X4
microtubule-associated protein tau isoform X13
microtubule-associated protein tau isoform X11
microtubule-associated protein tau isoform X8
microtubule-associated protein tau isoform X4
microtubule-associated protein tau isoform X12
microtubule-associated protein tau isoform X10
microtubule-associated protein tau isoform X5
microtubule-associated protein tau isoform X9
microtubule-associated protein tau isoform X6
microtubule-associated protein tau isoform X1
microtubule-associated protein tau isoform X3
microtubule associated protein tau, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule-associated protein tau isoform X14
microtubule-associated protein tau isoform X2
microtubule associated protein tau, transcript variant X8
microtubule-associated protein tau isoform X7
microtubule associated protein tau, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 25 member 39
RUN domain containing 3A, transcript variant X7
RUN domain containing 3A, transcript variant X12
RUN domain containing 3A, transcript variant X9
RUN domain containing 3A, transcript variant X2
RUN domain containing 3A, transcript variant X1
RUN domain containing 3A, transcript variant X6
RUN domain containing 3A, transcript variant X14
RUN domain containing 3A, transcript variant X13
RUN domain containing 3A, transcript variant X4
RUN domain containing 3A, transcript variant X3
RUN domain containing 3A, transcript variant X8
RUN domain containing 3A, transcript variant X5
RUN domain containing 3A, transcript variant X10
RUN domain containing 3A, transcript variant X11
RUN domain-containing protein 3A isoform X2
RUN domain-containing protein 3A isoform X6
RUN domain-containing protein 3A isoform X1
RUN domain-containing protein 3A isoform X8
RUN domain-containing protein 3A isoform X3
RUN domain-containing protein 3A isoform X9
RUN domain-containing protein 3A isoform X4
RUN domain-containing protein 3A isoform X5
RUN domain-containing protein 3A isoform X7
RUN domain-containing protein 3A isoform X10
solute carrier family 4 member 1 (Diego blood group), transcript variant X1
solute carrier family 4 member 1 (Diego blood group), transcript variant X2
solute carrier family 4 member 1 (Diego blood group), transcript variant X4
solute carrier family 4 member 1 (Diego blood group), transcript variant X3
band 3 anion transport protein isoform X1
band 3 anion transport protein isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nucleolar transcription factor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ataxin-7-like protein 3
transmembrane and ubiquitin like domain containing 2
transmembrane and ubiquitin-like domain-containing protein 2
ankyrin repeat and SOCS box containing 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 16, transcript variant X6
ankyrin repeat and SOCS box containing 16, transcript variant X5
ankyrin repeat and SOCS box protein 16 isoform X4
ankyrin repeat and SOCS box protein 16 isoform X3
ankyrin repeat and SOCS box containing 16, transcript variant X4
ankyrin repeat and SOCS box containing 16, transcript variant X3
ankyrin repeat and SOCS box containing 16, transcript variant X1
ankyrin repeat and SOCS box protein 16 isoform X2
ankyrin repeat and SOCS box protein 16 isoform X1
homologous recombination factor with OB-fold, transcript variant X1
homologous recombination factor with OB-fold, transcript variant X2
homologous recombination OB-fold protein isoform X1
homologous recombination OB-fold protein isoform X2
histone deacetylase 5, transcript variant X6
histone deacetylase 5, transcript variant X5
histone deacetylase 5, transcript variant X7
histone deacetylase 5, transcript variant X9
histone deacetylase 5, transcript variant X1
histone deacetylase 5, transcript variant X2
histone deacetylase 5, transcript variant X8
histone deacetylase 5, transcript variant X3
histone deacetylase 5, transcript variant X4
glucose-6-phosphatase catalytic subunit 3, transcript variant X1
glucose-6-phosphatase catalytic subunit 3, transcript variant X4
glucose-6-phosphatase catalytic subunit 3, transcript variant X3
glucose-6-phosphatase catalytic subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
N-acetylglutamate synthase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC119849015 isoform X1
membrane palmitoylated protein 2, transcript variant X3
membrane palmitoylated protein 2, transcript variant X4
membrane palmitoylated protein 2, transcript variant X1
membrane palmitoylated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sarcoglycan alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatid-specific linker histone H1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
protein phosphatase 1 regulatory subunit 9B, transcript variant X1
protein phosphatase 1 regulatory subunit 9B, transcript variant X2
protein phosphatase 1 regulatory subunit 9B, transcript variant X3
protein phosphatase 1 regulatory subunit 9B, transcript variant X4
sterile alpha motif domain containing 14, transcript variant X1
sterile alpha motif domain containing 14, transcript variant X3
sterile alpha motif domain containing 14, transcript variant X2
sterile alpha motif domain-containing protein 14 isoform X1
sterile alpha motif domain-containing protein 14 isoform X2
pyruvate dehydrogenase kinase 2, transcript variant X1
pyruvate dehydrogenase kinase, isozyme 2 isoform X1
pyruvate dehydrogenase kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
pyruvate dehydrogenase kinase, isozyme 2 isoform X2
integrin subunit alpha 3, transcript variant X1
integrin subunit alpha 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 long SRA reads, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC119849012, transcript variant X3
uncharacterized LOC119849012, transcript variant X1
uncharacterized LOC119849012, transcript variant X2
lysine acetyltransferase 7, transcript variant X1
lysine acetyltransferase 7, transcript variant X2
histone acetyltransferase KAT7 isoform X1
histone acetyltransferase KAT7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
family with sequence similarity 117 member A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 35 member B1
uncharacterized LOC119848898, transcript variant X2
uncharacterized LOC119848898, transcript variant X1
uncharacterized LOC119848898, transcript variant X3
speckle type BTB/POZ protein, transcript variant X11
speckle type BTB/POZ protein, transcript variant X1
speckle type BTB/POZ protein, transcript variant X4
speckle type BTB/POZ protein, transcript variant X3
speckle type BTB/POZ protein, transcript variant X7
speckle type BTB/POZ protein, transcript variant X6
speckle type BTB/POZ protein, transcript variant X8
speckle type BTB/POZ protein, transcript variant X2
speckle type BTB/POZ protein, transcript variant X5
speckle type BTB/POZ protein, transcript variant X10
speckle type BTB/POZ protein, transcript variant X12
speckle type BTB/POZ protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 16
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
zinc finger protein 652, transcript variant X3
zinc finger protein 652, transcript variant X1
zinc finger protein 652, transcript variant X2
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X1
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X2
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X3
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X5
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X6
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X4
phosphoethanolamine/phosphocholine phosphatase
ABI family member 3, transcript variant X3
ABI family member 3, transcript variant X1
ABI family member 3, transcript variant X4
ABI family member 3, transcript variant X2
G protein subunit gamma transducin 2, transcript variant X1
G protein subunit gamma transducin 2, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X5
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X7
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X2
beta-1,4 N-acetylgalactosaminyltransferase 2-like isoform X2
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X1
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,4 N-acetylgalactosaminyltransferase 2-like isoform X1
beta-1,4 N-acetylgalactosaminyltransferase 2-like isoform X5
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X3
beta-1,4 N-acetylgalactosaminyltransferase 2-like isoform X3
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X6
beta-1,4 N-acetylgalactosaminyltransferase 2-like isoform X4
insulin like growth factor 2 mRNA binding protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: insulin-like growth factor 2 mRNA-binding protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
SNF8 subunit of ESCRT-II, transcript variant X1
vacuolar-sorting protein SNF8 isoform X1
SNF8 subunit of ESCRT-II, transcript variant X2
vacuolar-sorting protein SNF8 isoform X2
ATP synthase F(0) complex subunit C1, mitochondrial
calcium binding and coiled-coil domain 2, transcript variant X2
calcium binding and coiled-coil domain 2, transcript variant X1
calcium-binding and coiled-coil domain-containing protein 2 isoform X1
calcium-binding and coiled-coil domain-containing protein 2 isoform X2
tubulin tyrosine ligase like 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubulin tyrosine ligase like 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubulin polyglutamylase TTLL6 isoform X1
tubulin polyglutamylase TTLL6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC119849192, transcript variant X1
uncharacterized LOC119849192, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 5 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: homeobox protein Hox-B8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor, erythroid 2 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
nuclear factor, erythroid 2 like 1, transcript variant X2
nuclear factor, erythroid 2 like 1, transcript variant X1
endoplasmic reticulum membrane sensor NFE2L1
COPI coat complex subunit zeta 2, transcript variant X2
COPI coat complex subunit zeta 2, transcript variant X6
COPI coat complex subunit zeta 2, transcript variant X1
COPI coat complex subunit zeta 2, transcript variant X5
COPI coat complex subunit zeta 2, transcript variant X4
COPI coat complex subunit zeta 2, transcript variant X3
proline rich 15 like, transcript variant X2
CDK5 regulatory subunit associated protein 3, transcript variant X3
CDK5 regulatory subunit associated protein 3, transcript variant X1
CDK5 regulatory subunit associated protein 3, transcript variant X4
CDK5 regulatory subunit associated protein 3, transcript variant X2
CDK5 regulatory subunit-associated protein 3 isoform X3
CDK5 regulatory subunit-associated protein 3 isoform X1
CDK5 regulatory subunit-associated protein 3 isoform X4
CDK5 regulatory subunit-associated protein 3 isoform X2
proline rich 15 like, transcript variant X1
uncharacterized LOC119849169, transcript variant X1
uncharacterized LOC119849169, transcript variant X5
uncharacterized LOC119849169, transcript variant X7
uncharacterized LOC119849169, transcript variant X2
uncharacterized LOC119849169, transcript variant X6
uncharacterized LOC119849169, transcript variant X8
uncharacterized LOC119849169, transcript variant X4
uncharacterized LOC119849169, transcript variant X3
uncharacterized protein LOC119849169 isoform X2
uncharacterized protein LOC119849169 isoform X3
uncharacterized protein LOC119849169 isoform X1
Sp2 transcription factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Sp2 transcription factor, transcript variant X1
Sp2 transcription factor, transcript variant X2
Sp2 transcription factor, transcript variant X4
Sp2 transcription factor, transcript variant X3
Sp2 transcription factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 46
39S ribosomal protein L10, mitochondrial
oxysterol binding protein like 7, transcript variant X1
oxysterol binding protein like 7, transcript variant X2
oxysterol-binding protein-related protein 7 isoform X1
oxysterol-binding protein-related protein 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
39S ribosomal protein L45, mitochondrial
suppressor of cytokine signaling 7, transcript variant X1
suppressor of cytokine signaling 7, transcript variant X3
suppressor of cytokine signaling 7, transcript variant X4
suppressor of cytokine signaling 7, transcript variant X2
suppressor of cytokine signaling 7, transcript variant X5
suppressor of cytokine signaling 7 isoform X1
suppressor of cytokine signaling 7 isoform X3
suppressor of cytokine signaling 7 isoform X4
suppressor of cytokine signaling 7 isoform X2
suppressor of cytokine signaling 7 isoform X5
Rho GTPase activating protein 23, transcript variant X5
rho GTPase-activating protein 23 isoform X5
Rho GTPase activating protein 23, transcript variant X4
rho GTPase-activating protein 23 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Rho GTPase activating protein 23, transcript variant X1
Rho GTPase activating protein 23, transcript variant X2
Rho GTPase activating protein 23, transcript variant X3
rho GTPase-activating protein 23 isoform X1
rho GTPase-activating protein 23 isoform X2
rho GTPase-activating protein 23 isoform X3
Rho GTPase activating protein 23, transcript variant X6
rho GTPase-activating protein 23 isoform X6
Rho GTPase activating protein 23, transcript variant X7
rho GTPase-activating protein 23 isoform X7
SRC kinase signaling inhibitor 1, transcript variant X14
SRC kinase signaling inhibitor 1, transcript variant X2
SRC kinase signaling inhibitor 1, transcript variant X12
SRC kinase signaling inhibitor 1, transcript variant X11
SRC kinase signaling inhibitor 1, transcript variant X1
SRC kinase signaling inhibitor 1, transcript variant X7
SRC kinase signaling inhibitor 1, transcript variant X6
SRC kinase signaling inhibitor 1, transcript variant X4
SRC kinase signaling inhibitor 1, transcript variant X8
SRC kinase signaling inhibitor 1, transcript variant X16
SRC kinase signaling inhibitor 1, transcript variant X9
SRC kinase signaling inhibitor 1, transcript variant X10
SRC kinase signaling inhibitor 1 isoform X11
SRC kinase signaling inhibitor 1 isoform X2
SRC kinase signaling inhibitor 1 isoform X9
SRC kinase signaling inhibitor 1 isoform X8
SRC kinase signaling inhibitor 1 isoform X1
SRC kinase signaling inhibitor 1 isoform X4
SRC kinase signaling inhibitor 1 isoform X6
SRC kinase signaling inhibitor 1 isoform X7
SRC kinase signaling inhibitor 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SRC kinase signaling inhibitor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SRC kinase signaling inhibitor 1 isoform X10
SRC kinase signaling inhibitor 1 isoform X3
SRC kinase signaling inhibitor 1 isoform X13
SRC kinase signaling inhibitor 1, transcript variant X15
SRC kinase signaling inhibitor 1, transcript variant X5
SRC kinase signaling inhibitor 1, transcript variant X17
SRC kinase signaling inhibitor 1 isoform X12
SRC kinase signaling inhibitor 1 isoform X5
SRC kinase signaling inhibitor 1 isoform X14
elongin BC and polycomb repressive complex 2 associated protein
elongin BC and Polycomb repressive complex 2-associated protein
MLLT6, PHD finger containing, transcript variant X5
MLLT6, PHD finger containing, transcript variant X4
MLLT6, PHD finger containing, transcript variant X6
MLLT6, PHD finger containing, transcript variant X2
MLLT6, PHD finger containing, transcript variant X1
MLLT6, PHD finger containing, transcript variant X3
MLLT6, PHD finger containing, transcript variant X7
MLLT6, PHD finger containing, transcript variant X8
MLLT6, PHD finger containing, transcript variant X9
CDGSH iron sulfur domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
CDGSH iron sulfur domain 3, transcript variant X2
CDGSH iron sulfur domain 3, transcript variant X1
CDGSH iron-sulfur domain-containing protein 3, mitochondrial isoform X1
CDGSH iron-sulfur domain-containing protein 3, mitochondrial isoform X2
CDGSH iron-sulfur domain-containing protein 3, mitochondrial isoform X3
polycomb group ring finger 2, transcript variant X1
polycomb group ring finger 2, transcript variant X7
polycomb group ring finger 2, transcript variant X5
polycomb group ring finger 2, transcript variant X2
polycomb group ring finger 2, transcript variant X4
polycomb group ring finger 2, transcript variant X6
polycomb group ring finger 2, transcript variant X3
polycomb group RING finger protein 2 isoform X3
polycomb group RING finger protein 2 isoform X2
polycomb group RING finger protein 2 isoform X1
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
proteasome 20S subunit beta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
proteasome 20S subunit beta 3, transcript variant X2
proteasome subunit beta type-3 isoform X1
proteasome subunit beta type-3 isoform X2
proteasome 20S subunit beta 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
proteasome subunit beta type-3 isoform X3
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
phosphatidylinositol 5-phosphate 4-kinase type-2 beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CWC25 spliceosome associated protein homolog
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
chromosome 27 C17orf98 homolog, transcript variant X1
chromosome 27 C17orf98 homolog, transcript variant X2
uncharacterized protein C17orf98 homolog isoform X1
uncharacterized protein C17orf98 homolog isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00412
plexin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
plexin domain containing 1, transcript variant X2
plexin domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
plexin domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
plexin domain-containing protein 1 isoform X1
plexin domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
putative ADP-ribosylation factor-like protein 5C
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X1
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-1 isoform X2
voltage-dependent L-type calcium channel subunit beta-1 isoform X1
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent L-type calcium channel subunit beta-1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 77% coverage of the annotated genomic feature by RNAseq alignments
SH3 and cysteine-rich domain-containing protein 2
transcription factor CP2-like protein 1, transcript variant X1
transcription factor CP2-like protein 1, transcript variant X2
transcription factor CP2-like protein 1 isoform X1
transcription factor CP2-like protein 1 isoform X2
F-box and leucine rich repeat protein 20, transcript variant X4
F-box and leucine rich repeat protein 20, transcript variant X2
F-box and leucine rich repeat protein 20, transcript variant X3
F-box and leucine rich repeat protein 20, transcript variant X1
F-box and leucine rich repeat protein 20, transcript variant X8
F-box and leucine rich repeat protein 20, transcript variant X7
F-box and leucine rich repeat protein 20, transcript variant X5
F-box and leucine rich repeat protein 20, transcript variant X6
mediator complex subunit 1, transcript variant X1
mediator complex subunit 1, transcript variant X2
mediator of RNA polymerase II transcription subunit 1 isoform X1
mediator of RNA polymerase II transcription subunit 1 isoform X2
cyclin dependent kinase 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cyclin dependent kinase 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
cyclin dependent kinase 12, transcript variant X1
cyclin dependent kinase 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 1B, transcript variant X2
protein phosphatase 1 regulatory inhibitor subunit 1B, transcript variant X1
protein phosphatase 1 regulatory subunit 1B
StAR related lipid transfer domain containing 3, transcript variant X2
StAR related lipid transfer domain containing 3, transcript variant X1
StAR related lipid transfer domain containing 3, transcript variant X4
StAR related lipid transfer domain containing 3, transcript variant X5
StAR related lipid transfer domain containing 3, transcript variant X3
StAR related lipid transfer domain containing 3, transcript variant X6
stAR-related lipid transfer protein 3 isoform X1
stAR-related lipid transfer protein 3 isoform X2
stAR-related lipid transfer protein 3 isoform X3
stAR-related lipid transfer protein 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
post-GPI attachment to proteins phospholipase 3, transcript variant X6
post-GPI attachment to proteins phospholipase 3, transcript variant X5
post-GPI attachment to proteins phospholipase 3, transcript variant X2
post-GPI attachment to proteins phospholipase 3, transcript variant X1
post-GPI attachment to proteins phospholipase 3, transcript variant X3
post-GPI attachment to proteins phospholipase 3, transcript variant X9
post-GPI attachment to proteins phospholipase 3, transcript variant X4
post-GPI attachment to proteins phospholipase 3, transcript variant X8
post-GPI attachment to proteins phospholipase 3, transcript variant X7
post-GPI attachment to proteins factor 3 isoform X4
post-GPI attachment to proteins factor 3 isoform X6
post-GPI attachment to proteins factor 3 isoform X2
post-GPI attachment to proteins factor 3 isoform X3
post-GPI attachment to proteins factor 3 isoform X1
post-GPI attachment to proteins factor 3 isoform X5
growth factor receptor bound protein 7, transcript variant X1
growth factor receptor-bound protein 7 isoform X1
growth factor receptor bound protein 7, transcript variant X2
growth factor receptor-bound protein 7 isoform X2
growth factor receptor bound protein 7, transcript variant X3
growth factor receptor bound protein 7, transcript variant X4
growth factor receptor-bound protein 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein Aiolos
zona pellucida binding protein 2, transcript variant X2
zona pellucida binding protein 2, transcript variant X1
zona pellucida-binding protein 2 isoform X1
zona pellucida-binding protein 2 isoform X2
leucine-rich repeat-containing protein 3C
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X2
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X1
26S proteasome non-ATPase regulatory subunit 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: granulocyte colony-stimulating factor
mediator complex subunit 24, transcript variant X4
mediator complex subunit 24, transcript variant X6
mediator complex subunit 24, transcript variant X3
mediator complex subunit 24, transcript variant X2
mediator complex subunit 24, transcript variant X5
mediator complex subunit 24, transcript variant X1
mediator of RNA polymerase II transcription subunit 24 isoform X1
mediator of RNA polymerase II transcription subunit 24 isoform X5
mediator of RNA polymerase II transcription subunit 24 isoform X4
mediator of RNA polymerase II transcription subunit 24 isoform X3
mediator of RNA polymerase II transcription subunit 24 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01211
thyroid hormone receptor alpha, transcript variant X2
thyroid hormone receptor alpha isoform X2
thyroid hormone receptor alpha, transcript variant X1
thyroid hormone receptor alpha isoform X1
nuclear receptor subfamily 1 group D member 1, transcript variant X1
nuclear receptor subfamily 1 group D member 1, transcript variant X2
nuclear receptor subfamily 1 group D member 1 isoform X2
nuclear receptor subfamily 1 group D member 1 isoform X1
Rap guanine nucleotide exchange factor like 1
rap guanine nucleotide exchange factor-like 1
WAS/WASL interacting protein family member 2, transcript variant X1
WAS/WASL interacting protein family member 2, transcript variant X3
WAS/WASL interacting protein family member 2, transcript variant X2
WAS/WASL interacting protein family member 2, transcript variant X4
WAS/WASL-interacting protein family member 2
retinoic acid receptor alpha, transcript variant X2
retinoic acid receptor alpha, transcript variant X1
retinoic acid receptor alpha, transcript variant X3
gap junction protein delta 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction protein delta 3, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: translation initiation factor IF-2-like
insulin like growth factor binding protein 4, transcript variant X2
insulin like growth factor binding protein 4, transcript variant X1
insulin-like growth factor-binding protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122457676, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122457676, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122457676, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 134 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: keratin, type I cuticular Ha6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 144 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 202 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
keratin, type I cytoskeletal 14-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 191 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
keratin, type I cytoskeletal 14-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 188 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
keratin, type I cytoskeletal 14-like isoform X1
keratin, type I cytoskeletal 14-like isoform X3
keratin, type I cytoskeletal 14-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 198 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
keratin, type I cytoskeletal 14-like isoform X2
keratin, type I cytoskeletal 42-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
keratin, type I cytoskeletal 42-like isoform X2
keratin, type I cytoskeletal 42-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
keratin, type I cytoskeletal 19-like isoform X1
eukaryotic translation initiation factor 1
gastrin/cholecystokinin-like peptide, transcript variant X2
gastrin/cholecystokinin-like peptide, transcript variant X3
gastrin/cholecystokinin-like peptide, transcript variant X1
gastrin/cholecystokinin-like peptide isoform X1
gastrin/cholecystokinin-like peptide isoform X2
huntingtin associated protein 1, transcript variant X5
huntingtin associated protein 1, transcript variant X2
huntingtin associated protein 1, transcript variant X1
huntingtin-associated protein 1 isoform X1
huntingtin-associated protein 1 isoform X2
huntingtin associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
huntingtin associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
huntingtin-associated protein 1 isoform X5
huntingtin-associated protein 1 isoform X4
huntingtin-associated protein 1 isoform X3
junction plakoglobin, transcript variant X5
junction plakoglobin, transcript variant X2
junction plakoglobin, transcript variant X10
junction plakoglobin, transcript variant X1
junction plakoglobin, transcript variant X3
junction plakoglobin, transcript variant X8
junction plakoglobin, transcript variant X9
junction plakoglobin, transcript variant X7
junction plakoglobin, transcript variant X6
junction plakoglobin, transcript variant X4
prolyl 3-hydroxylase family member 4 (inactive), transcript variant X1
prolyl 3-hydroxylase family member 4 (inactive), transcript variant X2
endoplasmic reticulum protein SC65 isoform X2
endoplasmic reticulum protein SC65 isoform X1
FKBP prolyl isomerase 10, transcript variant X1
FKBP prolyl isomerase 10, transcript variant X2
peptidyl-prolyl cis-trans isomerase FKBP10 isoform X1
peptidyl-prolyl cis-trans isomerase FKBP10 isoform X2
5'-nucleotidase, cytosolic IIIB, transcript variant X3
5'-nucleotidase, cytosolic IIIB, transcript variant X2
5'-nucleotidase, cytosolic IIIB, transcript variant X1
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X2
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X1
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X3
ATP citrate lyase, transcript variant X3
ATP citrate lyase, transcript variant X1
ATP citrate lyase, transcript variant X2
ATP citrate lyase, transcript variant X4
outer dynein arm docking complex subunit 4, transcript variant X2
outer dynein arm docking complex subunit 4, transcript variant X1
outer dynein arm-docking complex subunit 4 isoform X1
outer dynein arm-docking complex subunit 4 isoform X2
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X2
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X4
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X1
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X1
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X2
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X5
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X3
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X3
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X2
dnaJ homolog subfamily C member 7 isoform X1
dnaJ homolog subfamily C member 7 isoform X2
NFKB inhibitor interacting Ras like 2, transcript variant X4
NFKB inhibitor interacting Ras like 2, transcript variant X2
NFKB inhibitor interacting Ras like 2, transcript variant X3
NFKB inhibitor interacting Ras like 2, transcript variant X1
NF-kappa-B inhibitor-interacting Ras-like protein 2
zinc finger protein 385C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 385C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
DExH-box helicase 58, transcript variant X2
DExH-box helicase 58, transcript variant X8
DExH-box helicase 58, transcript variant X5
DExH-box helicase 58, transcript variant X9
DExH-box helicase 58, transcript variant X3
DExH-box helicase 58, transcript variant X7
DExH-box helicase 58, transcript variant X6
DExH-box helicase 58, transcript variant X4
DExH-box helicase 58, transcript variant X1
DExH-box helicase 58, transcript variant X10
probable ATP-dependent RNA helicase DHX58 isoform X5
probable ATP-dependent RNA helicase DHX58 isoform X2
probable ATP-dependent RNA helicase DHX58 isoform X3
probable ATP-dependent RNA helicase DHX58 isoform X4
probable ATP-dependent RNA helicase DHX58 isoform X1
LOW QUALITY PROTEIN: histone acetyltransferase KAT2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RAB5C, member RAS oncogene family, transcript variant X2
RAB5C, member RAS oncogene family, transcript variant X1
potassium voltage-gated channel subfamily H member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
hypocretin neuropeptide precursor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
hypocretin neuropeptide precursor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
hypocretin neuropeptide precursor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: inactive phospholipase C-like protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: GH3 domain-containing protein
signal transducer and activator of transcription 5B-like
LOW QUALITY PROTEIN: signal transducer and activator of transcription 5B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
signal transducer and activator of transcription 5B-like, transcript variant X1
signal transducer and activator of transcription 5B-like, transcript variant X2
signal transducer and activator of transcription 5B-like isoform X1
signal transducer and activator of transcription 5B-like, transcript variant X3
signal transducer and activator of transcription 5B-like isoform X2
signal transducer and activator of transcription 3, transcript variant X3
signal transducer and activator of transcription 3, transcript variant X6
signal transducer and activator of transcription 3, transcript variant X4
signal transducer and activator of transcription 3, transcript variant X7
signal transducer and activator of transcription 3, transcript variant X5
signal transducer and activator of transcription 3, transcript variant X2
signal transducer and activator of transcription 3, transcript variant X1
signal transducer and activator of transcription 3 isoform X2
signal transducer and activator of transcription 3 isoform X3
signal transducer and activator of transcription 3 isoform X1
caveolae associated protein 1, transcript variant X6
caveolae associated protein 1, transcript variant X5
caveolae associated protein 1, transcript variant X4
caveolae associated protein 1, transcript variant X3
caveolae associated protein 1, transcript variant X2
caveolae associated protein 1, transcript variant X1
ATPase H+ transporting V0 subunit a1, transcript variant X11
ATPase H+ transporting V0 subunit a1, transcript variant X12
ATPase H+ transporting V0 subunit a1, transcript variant X2
ATPase H+ transporting V0 subunit a1, transcript variant X4
ATPase H+ transporting V0 subunit a1, transcript variant X9
ATPase H+ transporting V0 subunit a1, transcript variant X10
ATPase H+ transporting V0 subunit a1, transcript variant X13
ATPase H+ transporting V0 subunit a1, transcript variant X1
ATPase H+ transporting V0 subunit a1, transcript variant X3
ATPase H+ transporting V0 subunit a1, transcript variant X5
ATPase H+ transporting V0 subunit a1, transcript variant X8
ATPase H+ transporting V0 subunit a1, transcript variant X6
ATPase H+ transporting V0 subunit a1, transcript variant X7
V-type proton ATPase 116 kDa subunit a1 isoform X7
V-type proton ATPase 116 kDa subunit a1 isoform X1
V-type proton ATPase 116 kDa subunit a1 isoform X2
V-type proton ATPase 116 kDa subunit a1 isoform X3
V-type proton ATPase 116 kDa subunit a1 isoform X5
V-type proton ATPase 116 kDa subunit a1 isoform X4
V-type proton ATPase 116 kDa subunit a1 isoform X6
serine/threonine-protein kinase 17A-like, transcript variant X1
serine/threonine-protein kinase 17A-like, transcript variant X2
serine/threonine-protein kinase 17A-like isoform X1
serine/threonine-protein kinase 17A-like isoform X2
hydroxysteroid 17-beta dehydrogenase 1, transcript variant X1
hydroxysteroid 17-beta dehydrogenase 1, transcript variant X2
hydroxysteroid 17-beta dehydrogenase 1, transcript variant X3
17-beta-hydroxysteroid dehydrogenase type 1 isoform X1
17-beta-hydroxysteroid dehydrogenase type 1 isoform X2
17-beta-hydroxysteroid dehydrogenase type 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Coenzyme A synthase, transcript variant X1
Coenzyme A synthase, transcript variant X2
coenzyme Q-binding protein COQ10 homolog B, mitochondrial-like
MAX dimerization protein MLX, transcript variant X1
MAX dimerization protein MLX, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
reticulophagy regulator family member 3, transcript variant X1
reticulophagy regulator family member 3, transcript variant X2
pleckstrin homology, MyTH4 and FERM domain containing H3, transcript variant X2
pleckstrin homology, MyTH4 and FERM domain containing H3, transcript variant X1
pleckstrin homology domain-containing family H member 3 isoform X2
pleckstrin homology domain-containing family H member 3 isoform X1
C-C motif chemokine receptor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
C-C motif chemokine receptor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: contactin-associated protein 1
enhancer of zeste 1 polycomb repressive complex 2 subunit
LOW QUALITY PROTEIN: histone-lysine N-methyltransferase EZH1
receptor activity-modifying protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 78% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
receptor activity modifying protein 2, transcript variant X1
receptor activity modifying protein 2, transcript variant X3
receptor activity modifying protein 2, transcript variant X2
receptor activity-modifying protein 2 isoform X1
receptor activity-modifying protein 2 isoform X2
receptor activity-modifying protein 2 isoform X3
vacuolar protein sorting 25 homolog, transcript variant X2
vacuolar protein sorting 25 homolog, transcript variant X1
vacuolar protein-sorting-associated protein 25 isoform X2
vacuolar protein-sorting-associated protein 25 isoform X1
vacuolar protein sorting 25 homolog, transcript variant X3
vacuolar protein-sorting-associated protein 25 isoform X3
WNK lysine deficient protein kinase 4, transcript variant X3
WNK lysine deficient protein kinase 4, transcript variant X4
WNK lysine deficient protein kinase 4, transcript variant X1
WNK lysine deficient protein kinase 4, transcript variant X2
serine/threonine-protein kinase WNK4 isoform X1
serine/threonine-protein kinase WNK4 isoform X2
serine/threonine-protein kinase WNK4 isoform X4
serine/threonine-protein kinase WNK4 isoform X3
WNK lysine deficient protein kinase 4, transcript variant X5
serine/threonine-protein kinase WNK4 isoform X5
cytochrome c oxidase assembly factor 3 homolog, mitochondrial
cyclin N-terminal domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
proteasome activator subunit 3, transcript variant X4
proteasome activator subunit 3, transcript variant X1
proteasome activator subunit 3, transcript variant X2
proteasome activator complex subunit 3 isoform X2
proteasome activator complex subunit 3 isoform X1
proteasome activator subunit 3, transcript variant X3
proteasome activator complex subunit 3 isoform X3
membrane primary amine oxidase-like, transcript variant X2
membrane primary amine oxidase-like isoform X2
amine oxidase copper containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane primary amine oxidase-like, transcript variant X1
membrane primary amine oxidase-like isoform X1
membrane primary amine oxidase isoform X1
amine oxidase copper containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
amine oxidase copper containing 3, transcript variant X2
membrane primary amine oxidase isoform X2
membrane primary amine oxidase isoform X3
glucose-6-phosphatase catalytic subunit 1-like
glucose-6-phosphatase catalytic subunit 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
glucose-6-phosphatase catalytic subunit 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
glucose-6-phosphatase catalytic subunit 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
glucose-6-phosphatase catalytic subunit 1-like isoform X1
glucose-6-phosphatase catalytic subunit 1-like isoform X2
glucose-6-phosphatase catalytic subunit 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative protein PTGES3L, transcript variant X7
putative protein PTGES3L, transcript variant X2
putative protein PTGES3L, transcript variant X1
putative protein PTGES3L, transcript variant X3
putative protein PTGES3L, transcript variant X4
alanyl-tRNA editing protein Aarsd1-like isoform X3
alanyl-tRNA editing protein Aarsd1-like isoform X1
putative protein PTGES3L, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative protein PTGES3L, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
RUN domain containing 1, transcript variant X1
RUN domain containing 1, transcript variant X2
RUN domain containing 1, transcript variant X3
RUN domain-containing protein 1 isoform X1
RUN domain-containing protein 1 isoform X2
RUN domain-containing protein 1 isoform X3
interferon induced protein 35, transcript variant X1
interferon induced protein 35, transcript variant X4
interferon induced protein 35, transcript variant X2
interferon induced protein 35, transcript variant X5
interferon induced protein 35, transcript variant X3
interferon induced protein 35, transcript variant X6
interferon-induced 35 kDa protein isoform X1
interferon-induced 35 kDa protein isoform X4
interferon-induced 35 kDa protein isoform X2
interferon-induced 35 kDa protein isoform X5
interferon-induced 35 kDa protein isoform X3
interferon-induced 35 kDa protein isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
synaptic vesicle membrane protein VAT-1 homolog
LOW QUALITY PROTEIN: rho-related GTP-binding protein RhoN
BRCA1 DNA repair associated, transcript variant X2
BRCA1 DNA repair associated, transcript variant X1
BRCA1 DNA repair associated, transcript variant X3
breast cancer type 1 susceptibility protein isoform X1
BRCA1 DNA repair associated, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BRCA1 DNA repair associated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BRCA1 DNA repair associated, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BRCA1 DNA repair associated, transcript variant X7
breast cancer type 1 susceptibility protein isoform X2
NBR1 autophagy cargo receptor, transcript variant X3
NBR1 autophagy cargo receptor, transcript variant X1
NBR1 autophagy cargo receptor, transcript variant X2
NBR1 autophagy cargo receptor, transcript variant X4
coiled-coil domain containing 200, transcript variant X1
coiled-coil domain containing 200, transcript variant X3
coiled-coil domain containing 200, transcript variant X2
coiled-coil domain-containing protein 200 isoform X3
coiled-coil domain-containing protein 200 isoform X2
coiled-coil domain-containing protein 200 isoform X1
ADP ribosylation factor like GTPase 4D, transcript variant X2
ADP ribosylation factor like GTPase 4D, transcript variant X1
ETS variant transcription factor 4, transcript variant X6
ETS variant transcription factor 4, transcript variant X4
ETS variant transcription factor 4, transcript variant X3
ETS variant transcription factor 4, transcript variant X5
ETS variant transcription factor 4, transcript variant X2
ETS variant transcription factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity phosphatase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity phosphatase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
dual specificity protein phosphatase 3 isoform X1
dual specificity protein phosphatase 3 isoform X2
dual specificity phosphatase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dual specificity phosphatase 3, transcript variant X3
dual specificity phosphatase 3, transcript variant X5
dual specificity protein phosphatase 3 isoform X5
dual specificity protein phosphatase 3 isoform X3
dual specificity protein phosphatase 3 isoform X4
sperm axonemal maintenance protein CFAP97D1
membrane palmitoylated protein 3, transcript variant X4
membrane palmitoylated protein 3, transcript variant X1
membrane palmitoylated protein 3, transcript variant X2
membrane palmitoylated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments